Review Article-Medulloblastomas: New Directions In Risk Stratification (original) (raw)
Medulloblastomas: New Directions In Risk Stratification
Prabal Deb
Neurology India, 2006
View PDFchevron_right
Pediatric medulloblastoma in the molecular era: what are the surgical implications?
Michelle Kameda-Smith
Cancer and Metastasis Reviews, 2020
View PDFchevron_right
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
Otilia Menyhart
Cancer and Metastasis Reviews, 2020
View PDFchevron_right
Clinical and molecular stratification of disease risk in medulloblastoma
J. Lunec
British journal of cancer, 2001
View PDFchevron_right
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Maura Massimino
Acta neuropathologica, 2016
View PDFchevron_right
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
Simon Bailey
Journal of Clinical Oncology, 2011
View PDFchevron_right
Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan
Alice Yu
Cancers, 2020
View PDFchevron_right
Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification
Nancy Tarbell
Nature Clinical Practice Oncology, 2007
View PDFchevron_right
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
Simon Bailey
The Lancet. Oncology, 2017
View PDFchevron_right
Clinical, Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease Risk Stratification System for Medulloblastoma
Peter McKinnon
Journal of Clinical Oncology, 2004
View PDFchevron_right
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome
Aviad Tsherniak
Journal of Clinical …, 2011
View PDFchevron_right
Molecular subgroups of medulloblastoma: the current consensus
Scott Pomeroy
Acta Neuropathologica, 2011
View PDFchevron_right
Prognostic Relevance of Clinical and Biological Risk Factors in Childhood Medulloblastoma: Results of Patients Treated in the Prospective Multicenter Trial HIT'91
Paul Schlegel
Clinical Cancer Research, 2007
View PDFchevron_right
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Wiesława Grajkowska
PLoS ONE, 2008
View PDFchevron_right
Molecular fingerprints of medulloblastoma and their application to clinical practice
Scott Pomeroy
Future Oncology, 2011
View PDFchevron_right
Prognostic Significance of Clinical, Histopathological, and Molecular Characteristics of Medulloblastomas in the Prospective HIT2000 Multicenter Clinical Trial Cohort
S. Rutkowski, H. Skladny
Neuro-Oncology, 2014
View PDFchevron_right
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Magnus Bäcklund
Acta Neuropathologica, 2012
View PDFchevron_right
The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined Therapies
PAOLO ALIMONTI
Cancers
View PDFchevron_right
Clinical and Molecular Parameters for Risk Stratification in Mexican Children with Medulloblastoma
Angel Aguilar Marquez
Archives of Medical Research, 2007
View PDFchevron_right
Case-based review: pediatric medulloblastoma
DAVID SOLOMON
Neuro-Oncology Practice
View PDFchevron_right
Medulloblastoma: From Molecular Pathology to Therapy
Krzysztof Reiss
Clinical Cancer Research, 2008
View PDFchevron_right
Medulloblastoma development: tumor biology informs treatment decisions
SOUMEN KHATUA
CNS oncology, 2015
View PDFchevron_right
The Molecular Landscape of Medulloblastoma in Teenagers and Young Adults
Omar Ahmad
Cancers, 2022
View PDFchevron_right
MBRS-10. Risk Stratification of Medulloblastoma on the Basis of Molecular Subgrouping; an Experience from a Single Tertiary Care Center from a Developing Country
quratulain riaz
Neuro-Oncology, 2018
View PDFchevron_right
Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen
gabriela lamas
Neuro-Oncology, 2020
View PDFchevron_right
Combining Gene Expression Profiles and Clinical Parameters for Risk Stratification in Medulloblastomas
PABLO TAMAYO
Journal of Clinical Oncology, 2004
View PDFchevron_right